Gene · 309
Papers2,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared genetic study gives insights into the shared and distinct pathogenic immunity components of IgA nephropathy and SLE. | Mol Genet Genomics | 2021 | 34076728 | PubTator, text mining | PubMed |
| Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation. | Genome Biol | 2021 | 34074348 | PubTator, text mining | PubMed |
| Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles. | Int J Mol Sci | 2021 | 34073560 | PubTator, text mining | PubMed |
| Annexins and Membrane Repair Dysfunctions in Muscular Dystrophies. | Int J Mol Sci | 2021 | 34067866 | PubTator, text mining | PubMed |
| Degradation Products of Complex Arabinoxylans by Bacteroides intestinalis Enhance the Host Immune Response. | Microorganisms | 2021 | 34067445 | PubTator, text mining | PubMed |
| Tubulin Beta 2C Chain (TBB2C), a Potential Marker of Ovarian Cancer, an Insight from Ovarian Cancer Proteome Profile. | ACS Omega | 2021 | 34056205 | PubTator, text mining | PubMed |
| miRcorrNet: machine learning-based integration of miRNA and mRNA expression profiles, combined with feature grouping and ranking. | PeerJ | 2021 | 34055490 | PubTator, text mining | PubMed |
| Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas. | Sci Rep | 2021 | 34045642 | PubTator, text mining | PubMed |
| circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. | Ann Rheum Dis | 2021 | 34039624 | PubTator, text mining | PubMed |
| The Anti-Viral and Anti-Inflammatory Properties of Edible Bird's Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application. | Front Pharmacol | 2021 | 34025406 | PubTator, text mining | PubMed |
| Activated fibroblasts enhance cancer cell migration by microvesicles-mediated transfer of Galectin-1. | J Cell Commun Signal | 2021 | 34021474 | PubTator, text mining | PubMed |
| Lysosome Function in Cardiovascular Diseases. | Cell Physiol Biochem | 2021 | 34019755 | PubTator, text mining | PubMed |
| Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome. | Front Immunol | 2021 | 34017338 | PubTator, text mining | PubMed |
| Bidirectional crosstalk between eosinophils and esophageal epithelial cells regulates inflammatory and remodeling processes. | Mucosal Immunol | 2021 | 33972688 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Matrilineal analysis of mutations in the DMD gene in a multigenerational South Indian cohort using DMD gene panel sequencing. | Mol Genet Genomic Med | 2021 | 33960727 | PubTator, text mining | PubMed |
| Defining the Caprin-1 Interactome in Unstressed and Stressed Conditions. | J Proteome Res | 2021 | 33939924 | PubTator, text mining | PubMed |
| Functions of Thrombospondin-1 in the Tumor Microenvironment. | Int J Mol Sci | 2021 | 33925464 | PubTator, text mining | PubMed |
| Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling. | Int J Mol Sci | 2021 | 33924522 | PubTator, text mining | PubMed |
| Annexins A2, A6 and Fetuin-A Affect the Process of Mineralization in Vesicles Derived from Human Osteoblastic hFOB 1.19 and Osteosarcoma Saos-2 Cells. | Int J Mol Sci | 2021 | 33924370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/309/papers?page=28